| First Author | Shimada T | Year | 1994 |
| Journal | J Dermatol Sci | Volume | 7 Suppl |
| Pages | S27-32 | PubMed ID | 7999674 |
| Mgi Jnum | J:22565 | Mgi Id | MGI:70424 |
| Doi | 10.1016/0923-1811(94)90032-9 | Citation | Shimada T, et al. (1994) Normalization of hair growth in sparse fur-abnormal skin and hair (SPF-ASH) mice by introduction of the rat ornithine transcarbamylase (OTC) gene. J Dermatol Sci 7 Suppl:S27-32 |
| abstractText | The sparse fur-abnormal skin and hair (SPF-ASH) mouse is a model for the human X-linked hereditary disease, ornithine transcarbamylase (OTC) deficiency. This condition is characterized by abnormal skin and delayed hair growth, hyperammonemia, orotic aciduria and low levels of serum citrulline and arginine. Murakami et al. [1] established a line of transgenic mice, by introducing the recombinant rat OTC (rOTC) gene into fertilized C57BL mouse eggs. We introduced the rOTC gene into SPF-ASH mice by mating SPF-ASH heterozygotes and transgenic mice, which carried this gene. The hemizygous SPF-ASH mice bearing the rOTC gene showed normal hair growth without sparse fur, normal urinary orotic acid excretion and normal serum citrulline and arginine levels. These mice showed OTC activities 2 and 6 times higher in the liver and small intestine, respectively, than the SPF-ASH mice but about 12% and 27% those of the controls [2]. |
